S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ONTX Onconova Therapeutics Inc

0.9953

0.00 (0.00%)

29 Nov 2024 - Closed

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

02/08/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Steven Fruchtman

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Onconova Therapeutics (NASDAQ:ONTX)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Onconova Therapeutics Charts.

Onconova Therapeutics (NASDAQ:ONTX)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Onconova Therapeutics Charts.

Onconova Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 10 February 2024 (10 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 10 February 2024 (10 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 9 February 2024 (10 months ago) • Edgar (US Regulatory)

More Onconova Therapeutics Inc News Articles

Commonwealth Bank Of Aus...

Australian SE All Ordina...

Sterling vs AUD

Newcrest Mining

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions